Industry placement | Protein Engineering; Antibody Platform

Year in Industry Placement | Protein Engineering (Antibody Platform)

Location of role: Oxford, UK

Department: Protein Engineering

Employment type: Contract

Job function: Research and Science

Seniority level: Internship

Get AI-powered advice on this job and more exclusive features.

We have an opportunity in our Research Group for a 12‑month placement (Year in industry). We are looking for enthusiastic and highly motivated individuals who would relish the chance to learn from Immunocore’s cutting‑edge science and corporate growth. The aim of this project is to generate an experimental dataset to assist the validation of a computational polyspecificity and develop ability workflow. The successful candidate will produce a diverse panel of VHH molecules, which will be run on multiple polyspecificity assays, generating the required data to compare to computational predictions and assess the performance of the in silico tools.

The candidate will have the opportunity to use high‑throughput automation approaches and collaborate with the develop ability and in silico groups within research.

The successful student will use molecular biology techniques (PCR and cloning) to produce constructs, in bacterial and mammalian expression vectors. After plasmid production, the student will use periplasmically expressed samples of the molecules to be used in polyspecificity assays at the cutting edge of develop ability research  candidate will also use CHO cell expression and purification to generate purified proteins, which can be used in assays to determine additional develop ability properties such as melting temperature (Tm) and aggregation propensity of each molecule.

With this generated data, the student can collaborate with the in silico modelling team and use a combination of computational predictions and experimental data to rank existing VHH molecules. The aim will be to generate a recommended set of alterations that could be made to existing molecules to improve their develop ability properties.

Currently studying towards a Biological Sciences, Biomedicine, Immunology, Biotechnology or (Bio)
Chemistry or other related degree.

Join Immunocore for a paid placement and gain insights from our innovative science and corporate growth. You’ll enjoy 25 days of annual leave (pro rata), pension scheme eligibility, and access to our active Sports and Social Club with subsidised events.

The Final date to receive applications is 09th January 2026, with phone interviews starting shortly after. Shortlisted candidates will be invited to an in‑person Assessment Centre on 23rd, 24th, 25th, or 26th February 2026, providing an opportunity to meet current placement students, learn about the role, and socialise with employees.

Placements are expected to begin on 7th September 2026.

Please note – if you are not available on all the above dates, unfortunately we won’t be able to proceed with your application.

Please only apply if you are currently undergoing a degree with a placement year (sandwich year).

If interested, apply with your CV and a cover letter (combined in one document) stating your main areas of interest.

Immunocore (NASDAQ: IMCR) is a pioneering, commercial‑stage T cell receptor biotechnology company whose purpose is to develop and commercialise a new generation of transformative medicines which address unmet patient needs in oncology, infectious diseases and autoimmune disease. Our leaders in R&D are internationally recognised as some of the biotech industry’s most successful drug developers. We are creating not just an environment where great minds can interact but an innovation powerhouse answering the big questions.

Focused on delivering first‑in‑class biological therapies to patients, we have developed a highly innovative soluble TCR platform. Our ImmTAX molecules underpin a new generation of precision‑engineered drugs that harness the immune system to treat a broad spectrum of diseases with high unmet medical need, including oncology, infectious diseases and autoimmune diseases.

At Immunocore, we…